Innoviva, Inc. (INVA) shareholders
Close on Nov 17, 2026Market cap $1.32BP/E 9.3Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 11,138,961 | 15.40% | 13G (passive) amendment | Sep 30, 2026 |
| Putnam Investments, LLC. d/b/a/ Putnam Investments Joint filing with Putnam Investment Management, LLC (9.80%), Putnam Global Health Care Fund (8.00%) | 6,270,413 | 9.80% | 13G (passive) amendment | Dec 31, 2023 |
| Renaissance Technologies Holdings Corporation Joint filing with Renaissance Technologies LLC (7.56%) | 4,760,832 | 7.56% | 13G (passive) amendment | Apr 1, 2025 |
| Dimensional Fund Advisors LP | 4,360,401 | 5.80% | 13G (passive) amendment | Dec 31, 2025 |
| Vanguard Portfolio Management | 4,288,063 | 5.79% | 13G (passive) | Mar 31, 2026 |
| Renaissance Technologies LLC Joint filing with Renaissance Technologies Holdings Corporation (5.63%) | 4,210,172 | 5.63% | 13G (passive) amendment | Dec 31, 2025 |
| Vanguard Capital Management | 3,704,185 | 5.01% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of INVA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 11,555,209 | 15.99% | $262.42M | +247,364 | 0.00% |
| Dimensional Fund Advisors LP | 4,494,053 | 6.22% | $102.06M | +57,626 | 0.02% |
| Vanguard Portfolio Management LLC | 4,220,273 | 5.84% | $95.84M | −4,678 | 0.00% |
| Renaissance Technologies LLC | 4,036,532 | 5.59% | $91.67M | −19,100 | 0.13% |
| State Street Corp | 3,268,004 | 4.52% | $74.22M | +207,627 | 0.00% |
| Vanguard Capital Management LLC | 3,158,053 | 4.37% | $71.72M | +16,472 | 0.00% |
| Millennium Management LLC | 2,541,109 | 3.52% | $57.71M | +261,658 | 0.02% |
| Geode Capital Management, LLC | 2,074,709 | 2.87% | $47.13M | +144,991 | 0.00% |
| Systematic Financial Management LP | 2,023,565 | 2.80% | $45.96M | −517 | 0.92% |
| Boston Partners | 1,927,959 | 2.67% | $43.78M | +209,092 | 0.04% |
| Sarissa Capital Management LP | 1,890,604 | 2.62% | $42.94M | −240,346 | 24.14% |
| Bank Of America Corp /De/ | 1,667,697 | 2.31% | $37.87M | +47,703 | 0.00% |
| Goldman Sachs Group Inc | 1,620,093 | 2.24% | $36.79M | +26,710 | 0.00% |
| American Century Companies Inc | 1,498,044 | 2.07% | $34.02M | −411,977 | 0.02% |
| Marshall Wace, Llp | 1,454,319 | 2.01% | $33.03M | −50,092 | 0.03% |
| Morgan Stanley | 1,220,831 | 1.69% | $27.73M | −89,919 | 0.00% |
| Royce & Associates LP | 1,172,690 | 1.62% | $26.63M | +111,242 | 0.21% |
| Charles Schwab Investment Management Inc | 1,151,307 | 1.59% | $26.15M | −12,406 | 0.00% |
| Two Sigma Investments, LP | 1,032,807 | 1.43% | $23.46M | −451,457 | 0.02% |
| Qube Research & Technologies Ltd | 974,124 | 1.35% | $22.12M | +188,017 | 0.02% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 308 | 75M | 100.0% | 47 / 133 | 84 / 21 | 6M | 6M |
| Q1 2026 | 286 | 76M | 100.0% | 48 / 116 | 87 / 37 | 15M | 7M |
| Q4 2025 | 281 | 76M | 100.0% | 47 / 102 | 92 / 27 | 8M | 8M |
| Q3 2025 | 264 | 76M | 100.0% | 38 / 101 | 84 / 37 | 8M | 7M |
| Q2 2025 | 266 | 75M | 100.0% | 47 / 106 | 81 / 23 | 12M | 5M |
| Q1 2025 | 246 | 68M | 94.1% | 39 / 83 | 89 / 24 | 8M | 11M |
| Q4 2024 | 235 | 71M | 98.6% | 35 / 96 | 62 / 21 | 6M | 8M |
| Q3 2024 | 221 | 73M | 100.0% | 24 / 76 | 85 / 15 | 13M | 4M |
| Q2 2024 | 213 | 73M | 100.0% | 25 / 79 | 81 / 26 | 5M | 7M |
| Q1 2024 | 216 | 76M | 100.0% | 34 / 75 | 73 / 14 | 11M | 5M |
| Q4 2023 | 197 | 75M | 100.0% | 29 / 67 | 71 / 24 | 11M | 4M |
| Q3 2023 | 192 | 68M | 94.6% | 17 / 61 | 88 / 22 | 3M | 5M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
314 funds held INVA in Q2 2026, 62% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of INVA | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 4,225,366 | 5.85% | $95.96M | 0.09% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 2,231,526 | 3.09% | $50.68M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,940,392 | 2.69% | $44.07M | 0.05% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 1,606,724 | 2.22% | $36.49M | 0.02% | Jun 30, 2026 |
| Avantis U.S. Small Cap Value ETF | 1,438,540 | 1.99% | $30.81M | 0.11% | May 31, 2026 |
| Vanguard Small-Cap Value Index Fund | 1,018,666 | 1.41% | $23.13M | 0.03% | Jun 30, 2026 |
| U.S. Small Cap Value Portfolio | 1,008,117 | 1.40% | $21.14M | 0.11% | Jul 31, 2026 |
| Fidelity Small Cap Index Fund | 825,816 | 1.14% | $17.32M | 0.05% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 803,258 | 1.11% | $18.24M | 0.02% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF | 707,315 | 0.98% | $16.06M | 0.11% | Jun 30, 2026 |
| Column Small Cap Select Fund | 660,021 | 0.91% | $14.14M | 0.75% | May 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 644,347 | 0.89% | $14.63M | 0.09% | Jun 30, 2026 |
| U.S. Targeted Value Portfolio | 551,001 | 0.76% | $11.55M | 0.07% | Jul 31, 2026 |
| Invesco Pharmaceuticals ETF | 544,496 | 0.75% | $11.42M | 2.42% | Jul 31, 2026 |
| Dimensional U.S. Targeted Value ETF | 508,220 | 0.70% | $10.66M | 0.07% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Pavel Raifeld | Chief Executive Officer, Director | 284,799 | 0.39% | Aug 24, 2026 |
| Stephen Basso | Chief Financial Officer | 88,013 | 0.12% | Aug 24, 2026 |
| Marianne Zhen | Chief Accounting Officer | 56,389 | 0.08% | Aug 24, 2026 |
| Josephine Linden | Director | 15,194 | 0.02% | May 20, 2026 |
| Derek A. Small | Director | 45,035 | 0.06% | May 6, 2026 |
| Sarah J. Schlesinger | Director | 140,492 | 0.19% | May 6, 2026 |
| Mark DiPaolo | Director | 140,492 | 0.19% | May 6, 2026 |
| Jules Haimovitz | Director | 152,692 | 0.21% | May 6, 2026 |
| Alexander J. Denner | 10% owner | 5,658,705 | 7.83% | Mar 17, 2025 |
| Capital Management LP Sarissa | 10% owner | 7,277,000 | 10.07% | Mar 17, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Stephen Basso Chief Financial Officer | Aug 20, 2026 | Tax withholding | −558 | $21.00 | $11.72K | 88,013 |
| Pavel Raifeld Chief Executive Officer, Director | Aug 20, 2026 | Tax withholding | −1,130 | $21.00 | $23.73K | 284,799 |
| Marianne Zhen Chief Accounting Officer | Aug 20, 2026 | Tax withholding | −1,127 | $21.00 | $23.67K | 56,389 |
| Marianne Zhen Chief Accounting Officer | May 20, 2026 | Tax withholding | −1,127 | $22.24 | $25.06K | 57,516 |
| Pavel Raifeld Chief Executive Officer, Director | May 20, 2026 | Tax withholding | −1,130 | $22.24 | $25.13K | 285,929 |
| Stephen Basso Chief Financial Officer | May 20, 2026 | Tax withholding | −559 | $22.24 | $12.43K | 88,571 |
| Josephine Linden Director | May 18, 2026 | Award | +9,461 | – | – | 15,194 |
| Josephine Linden Director | May 18, 2026 | Award | +5,733 | – | – | 5,733 |
| Pavel Raifeld Chief Executive Officer, Director | May 15, 2026 | Award | +1,123 | – | – | 287,059 |
| Stephen Basso Chief Financial Officer | May 15, 2026 | Award | +1,123 | – | – | 89,130 |
| Mark DiPaolo Director | May 4, 2026 | Award | +9,786 | – | – | 140,492 |
| Derek A. Small Director | May 4, 2026 | Award | +9,786 | – | – | 45,035 |
| Sarah J. Schlesinger Director | May 4, 2026 | Award | +9,786 | – | – | 140,492 |
| Pavel Raifeld Chief Executive Officer, Director | May 4, 2026 | Award | +126,646 | – | – | 285,936 |
| Marianne Zhen Chief Accounting Officer | May 4, 2026 | Award | +12,766 | – | – | 58,643 |
| Stephen Basso Chief Financial Officer | May 4, 2026 | Award | +37,994 | – | – | 88,007 |
| Jules Haimovitz Director | May 4, 2026 | Award | +9,786 | – | – | 152,692 |
| Stephen Basso Chief Financial Officer | Feb 20, 2026 | Tax withholding | −1,244 | $23.39 | $29.10K | 50,013 |
| Pavel Raifeld Chief Executive Officer, Director | Feb 20, 2026 | Tax withholding | −2,986 | $23.39 | $69.84K | 159,290 |
| Marianne Zhen Chief Accounting Officer | Feb 20, 2026 | Tax withholding | −2,460 | $23.39 | $57.54K | 45,877 |
| Marianne Zhen Chief Accounting Officer | Nov 20, 2025 | Tax withholding | −992 | $21.16 | $20.99K | 48,337 |
| Stephen Basso Chief Financial Officer | Nov 20, 2025 | Tax withholding | −237 | $21.16 | $5.01K | 51,257 |
| Stephen Basso Chief Financial Officer | Nov 15, 2025 | Award | +604 | – | – | 51,494 |
| Stephen Basso Chief Financial Officer | Nov 3, 2025 | Award | +27,609 | $18.11 | $500.00K | 50,890 |
| Pavel Raifeld 10% owner | Nov 3, 2025 | Award | +110,436 | $18.11 | $2.00M | 162,276 |
| Stephen Basso Chief Financial Officer | Aug 20, 2025 | Tax withholding | −237 | $19.95 | $4.73K | 23,281 |
| Marianne Zhen Chief Accounting Officer | Aug 20, 2025 | Tax withholding | −991 | $19.95 | $19.77K | 49,329 |
| Stephen Basso Chief Financial Officer | May 20, 2025 | Tax withholding | −237 | $18.78 | $4.45K | 23,518 |
| Marianne Zhen Chief Accounting Officer | May 20, 2025 | Tax withholding | −992 | $18.78 | $18.63K | 50,320 |
| Jules Haimovitz Director | May 19, 2025 | Award | +12,077 | – | – | 142,906 |
| Derek A. Small Director | May 19, 2025 | Award | +12,077 | – | – | 35,249 |
| Mark DiPaolo Director | May 19, 2025 | Award | +12,077 | – | – | 130,706 |
| Sarah J. Schlesinger Director | May 19, 2025 | Award | +12,077 | – | – | 130,706 |
| Pavel Raifeld 10% owner | May 15, 2025 | Award | +1,860 | – | – | 51,840 |
| Stephen Basso Chief Financial Officer | May 15, 2025 | Award | +1,353 | – | – | 23,755 |
| Pavel Raifeld 10% owner | Mar 14, 2025 | Award | +37,377 | $17.39 | $649.99K | 49,980 |
| Alexander J. Denner 10% owner | Mar 6, 2025 | Sale | −1,196,746 | $17.52 | $20.97M | 5,658,705 |
| Alexander J. Denner 10% owner | Mar 5, 2025 | Sale | −270,374 | $17.63 | $4.77M | 6,855,451 |
| Alexander J. Denner 10% owner | Mar 4, 2025 | Sale | −151,175 | $17.63 | $2.67M | 7,125,825 |
| Stephen Basso Chief Financial Officer | Feb 24, 2025 | Award | +10,569 | $18.08 | $191.09K | 22,402 |
| Marianne Zhen Chief Accounting Officer | Feb 24, 2025 | Award | +8,938 | $18.08 | $161.60K | 51,312 |
| Stephen Basso Chief Financial Officer | Feb 20, 2025 | Tax withholding | −1,106 | $18.07 | $19.99K | 11,833 |
| Marianne Zhen Chief Accounting Officer | Feb 20, 2025 | Tax withholding | −2,565 | $18.07 | $46.35K | 42,374 |
| Marianne Zhen Chief Accounting Officer | Nov 20, 2024 | Tax withholding | −976 | $19.15 | $18.69K | 44,939 |
| Stephen Basso Chief Financial Officer | Nov 15, 2024 | Award | +843 | – | – | 12,939 |
| Marianne Zhen Chief Accounting Officer | Nov 15, 2024 | Award | +300 | – | – | 45,915 |
| Marianne Zhen Chief Accounting Officer | Aug 20, 2024 | Tax withholding | −975 | $18.49 | $18.03K | 45,615 |
| Sarah J. Schlesinger Director | Jun 17, 2024 | Award | +13,923 | – | – | 118,629 |
| Sapna Srivastava Director | Jun 17, 2024 | Award | +13,923 | – | – | 44,096 |
| Mark DiPaolo Director | Jun 17, 2024 | Award | +13,923 | – | – | 118,629 |
| Derek A. Small Director | Jun 17, 2024 | Award | +13,923 | – | – | 23,172 |
| Jules Haimovitz Director | Jun 17, 2024 | Award | +13,923 | – | – | 130,829 |
| Kostas D. Odysseas Director | Jun 17, 2024 | Award | +13,923 | – | – | 122,625 |
| Matthew Ronsheim See Remarks | May 20, 2024 | Tax withholding | −268 | $16.13 | $4.32K | 40,510 |
| Marianne Zhen Chief Accounting Officer | May 20, 2024 | Tax withholding | −976 | $16.13 | $15.74K | 46,590 |
| Stephen Basso Chief Financial Officer | Mar 5, 2024 | Award | +12,096 | $14.88 | $179.99K | 12,096 |
| Matthew Ronsheim See Remarks | Mar 5, 2024 | Award | +12,768 | $14.88 | $189.99K | 40,778 |
| Marianne Zhen Chief Accounting Officer | Mar 5, 2024 | Award | +10,752 | $14.88 | $159.99K | 47,566 |
| Marianne Zhen Chief Accounting Officer | Feb 20, 2024 | Tax withholding | −2,862 | $15.80 | $45.22K | 36,814 |
| Matthew Ronsheim See Remarks | Feb 20, 2024 | Tax withholding | −807 | $15.80 | $12.75K | 28,010 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Innoviva's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,000 shares on Sep 16, 2026 over the last 90 days.
Congress trades
2 trades in Innoviva reported by 1 member of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| George Whitesides CA27 · spouse | Sold | Mar 25, 2025 | $250K–500K | Apr 23, 2025 |
| George Whitesides CA27 | Sold | Mar 24, 2025 | $50K–100K | Apr 23, 2025 |
See a number that looks wrong?